MSAM
DNA icon

Moloney Securities Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Moloney Securities Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-500
Closed -$6.69K – 496
2024
Q2 		$6.69K Hold
500
– – ﹤0.01% 459
2024
Q1 		$23.2K Sell
500
-1,500
-75% -$77.6K ﹤0.01% 442
2023
Q4 		$135K Hold
2,000
– – 0.02% 418
2023
Q3 		$145K Hold
2,000
– – 0.03% 392
2023
Q2 		$149K Sell
2,000
-38
-2% -$2.25K 0.03% 388
2023
Q1 		$108K Sell
2,038
-428
-17% -$27.1K 0.02% 393
2022
Q4 		$167K Buy
2,466
+803
+48% +$73.9K 0.04% 365
2022
Q3 		$207K Buy
+1,663
New +$198K 0.05% 332

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return